Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,200
Closed -$9K 5493
2020
Q1
$9K Sell
1,200
-9,500
-89% -$81.1K ﹤0.01% 5833
2019
Q4
$106K Buy
10,700
+8,800
+463% +$83.9K ﹤0.01% 5450
2019
Q3
$22K Buy
1,900
+1,200
+171% +$14.3K ﹤0.01% 6187
2019
Q2
$11K Buy
700
+200
+40% +$3.19K ﹤0.01% 6531
2019
Q1
$7K Sell
500
-1,400
-74% -$19.3K ﹤0.01% 6635
2018
Q4
$20K Buy
1,900
+500
+36% +$6.82K ﹤0.01% 5892
2018
Q3
$25K Sell
1,400
-300
-18% -$5.01K ﹤0.01% 6390
2018
Q2
$25K Buy
1,700
+1,500
+750% +$22.4K ﹤0.01% 6050
2018
Q1
$3K Sell
200
-100
-33% -$1.67K ﹤0.01% 6845
2017
Q4
$6K Sell
300
-4,000
-93% -$88.8K ﹤0.01% 6614
2017
Q3
$103K Buy
4,300
+3,400
+378% +$75.2K ﹤0.01% 4914
2017
Q2
$19K Sell
900
-3,000
-77% -$60.1K ﹤0.01% 5804
2017
Q1
$81K Sell
3,900
-800
-17% -$17.4K ﹤0.01% 5036
2016
Q4
$105K Sell
4,700
-21,500
-82% -$435K ﹤0.01% 4705
2016
Q3
$501K Buy
26,200
+23,000
+719% +$424K ﹤0.01% 3220
2016
Q2
$60K Sell
3,200
-11,500
-78% -$219K ﹤0.01% 4734
2016
Q1
$294K Sell
14,700
-500
-3% -$9.25K ﹤0.01% 3568
2015
Q4
$258K Buy
15,200
+11,900
+361% +$189K ﹤0.01% 3701
2015
Q3
$46K Buy
3,300
+200
+6% +$3.16K ﹤0.01% 5048
2015
Q2
$50K Buy
3,100
+900
+41% +$15.4K ﹤0.01% 5133
2015
Q1
$40K Sell
2,200
-4,500
-67% -$95.7K ﹤0.01% 5424
2014
Q4
$141K Buy
6,700
+500
+8% +$10.3K ﹤0.01% 4904
2014
Q3
$124K Sell
6,200
-1,900
-23% -$42.5K ﹤0.01% 5153
2014
Q2
$178K Buy
8,100
+1,100
+16% +$24.9K ﹤0.01% 4924
2014
Q1
$168K Sell
7,000
-1,400
-17% -$36.1K ﹤0.01% 4948
2013
Q4
$227K Sell
8,400
-23,200
-73% -$584K ﹤0.01% 4887
2013
Q3
$821K Sell
31,600
-31,700
-50% -$822K ﹤0.01% 3573
2013
Q2
$1.56M Buy
+63,300
New +$1.4M ﹤0.01% 2813

Other funds holding ADTN

Barclays's ADTN Position: Q1 2026 in Review

Barclays reduced its Adtran (ADTN) stake by 18% in Q1 2026, selling an estimated $2.01M and leaving 927,775 shares worth $11.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Barclays first reported a position in ADTN in Q2 2013 and has held it in 52 quarters since. 227 funds tracked by Wall St. Rank hold ADTN as of Q1 2026.

  • Barclays held 927,775 shares of Adtran worth $11.7M as of Q1 2026.
  • Barclays sold 197,928 Adtran shares in Q1 2026, an estimated $2.01M.
  • Adtran made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1374 holding.
  • Barclays first reported a position in Adtran in Q2 2013 and has held it in 52 quarters since.
  • 227 funds tracked by Wall St. Rank held Adtran as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.